The future of International Classification of Diseases coding in steatotic liver disease : An expert panel Delphi consensus statement
Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Association for the Study of Liver Diseases..
BACKGROUND: Following the adoption of new nomenclature for steatotic liver disease, we aimed to build consensus on the use of International Classification of Diseases codes and recommendations for future research and advocacy.
METHODS: Through a two-stage Delphi process, a core group (n = 20) reviewed draft statements and recommendations (n = 6), indicating levels of agreement. Following revisions, this process was repeated with a large expert panel (n = 243) from 73 countries.
RESULTS: Consensus ranged from 88.8% to 96.9% (mean = 92.3%).
CONCLUSIONS: This global consensus statement provides guidance on harmonizing the International Classification of Diseases coding for steatotic liver disease and future directions to advance the field.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
|---|---|
| Enthalten in: |
Hepatology communications - 8(2024), 2 vom: 01. Feb. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hagström, Hannes [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 07.02.2024 Date Revised 07.02.2024 published: Electronic-eCollection Citation Status MEDLINE |
|---|
| doi: |
10.1097/HC9.0000000000000386 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368043800 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368043800 | ||
| 003 | DE-627 | ||
| 005 | 20240207232321.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240206s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/HC9.0000000000000386 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1283.xml |
| 035 | |a (DE-627)NLM368043800 | ||
| 035 | |a (NLM)38315102 | ||
| 035 | |a (PII)e0386 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hagström, Hannes |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The future of International Classification of Diseases coding in steatotic liver disease |b An expert panel Delphi consensus statement |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 07.02.2024 | ||
| 500 | |a Date Revised 07.02.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Association for the Study of Liver Diseases. | ||
| 520 | |a BACKGROUND: Following the adoption of new nomenclature for steatotic liver disease, we aimed to build consensus on the use of International Classification of Diseases codes and recommendations for future research and advocacy | ||
| 520 | |a METHODS: Through a two-stage Delphi process, a core group (n = 20) reviewed draft statements and recommendations (n = 6), indicating levels of agreement. Following revisions, this process was repeated with a large expert panel (n = 243) from 73 countries | ||
| 520 | |a RESULTS: Consensus ranged from 88.8% to 96.9% (mean = 92.3%) | ||
| 520 | |a CONCLUSIONS: This global consensus statement provides guidance on harmonizing the International Classification of Diseases coding for steatotic liver disease and future directions to advance the field | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Adams, Leon A |e verfasserin |4 aut | |
| 700 | 1 | |a Allen, Alina M |e verfasserin |4 aut | |
| 700 | 1 | |a Byrne, Christopher D |e verfasserin |4 aut | |
| 700 | 1 | |a Chang, Yoosoo |e verfasserin |4 aut | |
| 700 | 1 | |a Duseja, Ajay |e verfasserin |4 aut | |
| 700 | 1 | |a Grønbæk, Henning |e verfasserin |4 aut | |
| 700 | 1 | |a Ismail, Mona H |e verfasserin |4 aut | |
| 700 | 1 | |a Jepsen, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Kanwal, Fasiha |e verfasserin |4 aut | |
| 700 | 1 | |a Kramer, Jennifer |e verfasserin |4 aut | |
| 700 | 1 | |a Loomba, Rohit |e verfasserin |4 aut | |
| 700 | 1 | |a Mark, Henry E |e verfasserin |4 aut | |
| 700 | 1 | |a Newsome, Philip N |e verfasserin |4 aut | |
| 700 | 1 | |a Rinella, Mary E |e verfasserin |4 aut | |
| 700 | 1 | |a Rowe, Ian A |e verfasserin |4 aut | |
| 700 | 1 | |a Ryu, Seungho |e verfasserin |4 aut | |
| 700 | 1 | |a Sanyal, Arun |e verfasserin |4 aut | |
| 700 | 1 | |a Schattenberg, Jörn M |e verfasserin |4 aut | |
| 700 | 1 | |a Serper, Marina |e verfasserin |4 aut | |
| 700 | 1 | |a Sheron, Nick |e verfasserin |4 aut | |
| 700 | 1 | |a Simon, Tracey G |e verfasserin |4 aut | |
| 700 | 1 | |a Spearman, C Wendy |e verfasserin |4 aut | |
| 700 | 1 | |a Tapper, Elliot B |e verfasserin |4 aut | |
| 700 | 1 | |a Villota-Rivas, Marcela |e verfasserin |4 aut | |
| 700 | 1 | |a Wild, Sarah H |e verfasserin |4 aut | |
| 700 | 1 | |a Wong, Vincent Wai-Sun |e verfasserin |4 aut | |
| 700 | 1 | |a Yilmaz, Yusuf |e verfasserin |4 aut | |
| 700 | 1 | |a Zelber-Sagi, Shira |e verfasserin |4 aut | |
| 700 | 1 | |a Åberg, Fredrik |e verfasserin |4 aut | |
| 700 | 1 | |a Lazarus, Jeffrey V |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Hepatology communications |d 2017 |g 8(2024), 2 vom: 01. Feb. |w (DE-627)NLM273051806 |x 2471-254X |7 nnns |
| 773 | 1 | 8 | |g volume:8 |g year:2024 |g number:2 |g day:01 |g month:02 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1097/HC9.0000000000000386 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2024 |e 2 |b 01 |c 02 | ||